CUSIP 59935V107COMMISTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
78 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Propel Bio Management, LLC | 4.12M | $8.32M | −1.01M | Reduced |
| 2 | Adage Capital Partners Gp, L.L.C. | 2.81M | $5.68M | −4.17M | Reduced |
| 3 | Rtw Investments, LP | 2.51M | $5.06M | 0 | Held |
| 4 | Marshall Wace, LLP | 1.66M | $3.35M |
| +1.23M |
| Added |
| 5 | Two Sigma Investments, LP | 1.51M | $3.06M | +847.9K | Added |
| 6 | Simplify Asset Management Inc. | 1.51M | $3.04M | −1.33M | Reduced |
| 7 | Jane Street Group, LLC | 1.09M | $2.21M | +684.7K | Added |
| 8 | Pathstone Holdings, LLC | 1.02M | $2.10M | +17.0K | Added |
| 9 | Morgan Stanley | 781.9K | $1.58M | −2.19M | Reduced |
| 10 | Lion Point Capital, LP | 755.0K | $1.53M | +96.4K | Added |
See every fund holding Milestone Pharmaceuticals In, with full quarter-over-quarter share changes.
Unlock all holders